Figure 2.
Efficacy of Tocilizumab therapy at 6 months. Mean A) DAS28-ESR, Tender Joint Counts (TJC) and Swollen Joint Counts (SJC) and B) CDAI, values at baseline and 6 months after Tocilizumab therapy. C) Percentage of patients achieved Good and Moderate response and Remission rates. NR: No response.